249 results
424B5
BPTH
Bio-Path Holdings Inc
19 Apr 24
Prospectus supplement for primary offering
3:28pm
pending the Panel’s decision. There can be no assurance that, if the Company does appeal the delisting determination by Nasdaq to the Panel … , there can be no assurance that the Company will be successful in developing the Compliance Plan, that the Compliance Plan will be accepted by Nasdaq, or even
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed
424B5
e6lnkk5g
19 Apr 24
Prospectus supplement for primary offering
9:17am
8-K
EX-10.1
j46mz
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm
424B5
ebc3i15
4 Apr 24
Prospectus supplement for primary offering
4:33pm
424B5
hsh1ii3u95jvo
27 Mar 24
Prospectus supplement for primary offering
8:15am
8-K
EX-10.1
ajcz62ovs
26 Mar 24
Entry into a Material Definitive Agreement
8:03am
8-K
2cenwx27w md
13 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm